tetano
Editor, Senior Moderator
Nat Commun
. 2024 Nov 20;15(1):10062.
doi: 10.1038/s41467-024-54404-w. Bias and negative values of COVID-19 vaccine effectiveness estimates from a test-negative design without controlling for prior SARS-CoV-2 infection
Ryan E Wiegand[SUP] 1 [/SUP], Bruce Fireman[SUP] 2 [/SUP], Morgan Najdowski[SUP] 3 [/SUP], Mark W Tenforde[SUP] 4 [/SUP], Ruth Link-Gelles[SUP] 3 [/SUP], Jill M Ferdinands[SUP] 4 [/SUP]
Affiliations
Test-negative designs (TNDs) are used to assess vaccine effectiveness (VE). Protection from infection-induced immunity may confound the association between case and vaccination status, but collecting reliable infection history can be challenging. If vaccinated individuals have less infection-induced protection than unvaccinated individuals, failure to account for infection history could underestimate VE, though the bias is not well understood. We simulated individual-level SARS-CoV-2 infection and COVID-19 vaccination histories and a TND. VE against symptomatic infection and VE against severe disease estimates unadjusted for infection history underestimated VE compared to estimates adjusted for infection history, and unadjusted estimates were more likely to be below 0%, which could lead to an incorrect interpretation that COVID-19 vaccines are harmful. TNDs assessing VE immediately following vaccine rollout introduced the largest bias and potential for negative VE against symptomatic infection. Despite the potential for bias, VE estimates from TNDs without prior infection information are useful because underestimation is rarely more than 8 percentage points.
. 2024 Nov 20;15(1):10062.
doi: 10.1038/s41467-024-54404-w. Bias and negative values of COVID-19 vaccine effectiveness estimates from a test-negative design without controlling for prior SARS-CoV-2 infection
Ryan E Wiegand[SUP] 1 [/SUP], Bruce Fireman[SUP] 2 [/SUP], Morgan Najdowski[SUP] 3 [/SUP], Mark W Tenforde[SUP] 4 [/SUP], Ruth Link-Gelles[SUP] 3 [/SUP], Jill M Ferdinands[SUP] 4 [/SUP]
Affiliations
- PMID: 39567531
- DOI: 10.1038/s41467-024-54404-w
Test-negative designs (TNDs) are used to assess vaccine effectiveness (VE). Protection from infection-induced immunity may confound the association between case and vaccination status, but collecting reliable infection history can be challenging. If vaccinated individuals have less infection-induced protection than unvaccinated individuals, failure to account for infection history could underestimate VE, though the bias is not well understood. We simulated individual-level SARS-CoV-2 infection and COVID-19 vaccination histories and a TND. VE against symptomatic infection and VE against severe disease estimates unadjusted for infection history underestimated VE compared to estimates adjusted for infection history, and unadjusted estimates were more likely to be below 0%, which could lead to an incorrect interpretation that COVID-19 vaccines are harmful. TNDs assessing VE immediately following vaccine rollout introduced the largest bias and potential for negative VE against symptomatic infection. Despite the potential for bias, VE estimates from TNDs without prior infection information are useful because underestimation is rarely more than 8 percentage points.